Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Health Experts Push To Centre Health In Climate Action At World Health Summit 29/10/2019 Elaine Ruth Fletcher Berlin, Germany (29 October 2019) – Experts called on policy-makers to put human health and wellbeing at the centre of climate action decisions at the World Health Summit, which entered its third and final day Tuesday. “There is a need for urgent action to reduce greenhouse emissions to protect health, because we have less than […] Continue reading -> WHO Launches Digital Health Action Plan To Guide Expert Group’s Work 25/10/2019 Grace Ren The World Health Organization has launched a plan to accelerate the use of digital technologies to meet global public health needs, following the first-ever meeting of a WHO Technical Advisory Group on digital health. “All governments are facing increasing demands to provide health services to their citizens, and many digital technologies offer solutions to help meet […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Fueling An Unhealthy Future – Report Sheds New Light On Health Costs of Fossil Fuel Subsidies 26/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Globally, governments are spending nearly $US 300 billion in price supports and other pre-tax subsidies for fossil fuels – which are costing national governments a whopping $US 2.7 trillion in health costs from air pollution-related mortality, disease and lost productivity—not to mention fueling climate change. As just one stunning example of […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
Health Experts Push To Centre Health In Climate Action At World Health Summit 29/10/2019 Elaine Ruth Fletcher Berlin, Germany (29 October 2019) – Experts called on policy-makers to put human health and wellbeing at the centre of climate action decisions at the World Health Summit, which entered its third and final day Tuesday. “There is a need for urgent action to reduce greenhouse emissions to protect health, because we have less than […] Continue reading -> WHO Launches Digital Health Action Plan To Guide Expert Group’s Work 25/10/2019 Grace Ren The World Health Organization has launched a plan to accelerate the use of digital technologies to meet global public health needs, following the first-ever meeting of a WHO Technical Advisory Group on digital health. “All governments are facing increasing demands to provide health services to their citizens, and many digital technologies offer solutions to help meet […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Fueling An Unhealthy Future – Report Sheds New Light On Health Costs of Fossil Fuel Subsidies 26/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Globally, governments are spending nearly $US 300 billion in price supports and other pre-tax subsidies for fossil fuels – which are costing national governments a whopping $US 2.7 trillion in health costs from air pollution-related mortality, disease and lost productivity—not to mention fueling climate change. As just one stunning example of […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
WHO Launches Digital Health Action Plan To Guide Expert Group’s Work 25/10/2019 Grace Ren The World Health Organization has launched a plan to accelerate the use of digital technologies to meet global public health needs, following the first-ever meeting of a WHO Technical Advisory Group on digital health. “All governments are facing increasing demands to provide health services to their citizens, and many digital technologies offer solutions to help meet […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Fueling An Unhealthy Future – Report Sheds New Light On Health Costs of Fossil Fuel Subsidies 26/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Globally, governments are spending nearly $US 300 billion in price supports and other pre-tax subsidies for fossil fuels – which are costing national governments a whopping $US 2.7 trillion in health costs from air pollution-related mortality, disease and lost productivity—not to mention fueling climate change. As just one stunning example of […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Fueling An Unhealthy Future – Report Sheds New Light On Health Costs of Fossil Fuel Subsidies 26/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Globally, governments are spending nearly $US 300 billion in price supports and other pre-tax subsidies for fossil fuels – which are costing national governments a whopping $US 2.7 trillion in health costs from air pollution-related mortality, disease and lost productivity—not to mention fueling climate change. As just one stunning example of […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
Fueling An Unhealthy Future – Report Sheds New Light On Health Costs of Fossil Fuel Subsidies 26/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Globally, governments are spending nearly $US 300 billion in price supports and other pre-tax subsidies for fossil fuels – which are costing national governments a whopping $US 2.7 trillion in health costs from air pollution-related mortality, disease and lost productivity—not to mention fueling climate change. As just one stunning example of […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
Drug R&D, Sexual & Reproductive Health Scrutinised In Draft UHC Declaration 19/07/2019 David Branigan Disclosure of costs for drug research and development (R&D) and “alternative financing mechanisms” for new health products remain outstanding points to be resolved by countries in finalising a draft United Nations General Assembly political declaration on universal health coverage (UHC). A final draft of the declaration had been expected this week, but as of Friday […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts
Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> Posts navigation Older postsNewer posts